Proof-of-Concept Funding

Proof-of-concept (PoC) funding is a category of small, milestone-based, non-dilutive awards used to test and demonstrate the technical or commercial feasibility of a discovery that has already been made. It sits in the gap between a research finding and a patentable, licensable or investable technology — the stretch where a result is too developed to need more basic research funding and too undeveloped for a licensee or investor to take on.

The defining feature: it starts from an existing result

PoC funding is distinguished from earlier-stage support by its starting point rather than its size. It assumes a specific invention or result already exists — often already the subject of an invention disclosure or a provisional patent filing — and uses the award to move that specific result forward. It does not fund open-ended exploration to see what might turn up.

That is the practical difference from seed funding, which asks whether a research idea deserves initial support to generate preliminary data for a larger grant, and is judged against research-progress criteria. PoC funding asks whether an existing finding is viable enough to license, spin out, or attract outside investment, and is judged against technology-readiness or commercialization milestones.

What the money is spent on

• Prototype development — building or refining a working prototype beyond a lab-scale or bench result, including scale-up and manufacturability testing.
• Technical de-risking — the specific experiment a sceptical licensee would demand: reproducibility in an independent setting, performance against an existing product, stability, or a validation study in a more realistic model.
• Intellectual property work — freedom-to-operate screening, prior-art searching, and provisional or national-phase patent filing costs.
• Market and stakeholder validation — structured interviews with potential licensees, customers, clinicians or investors to establish whether the problem the technology solves is one anyone will pay to solve.
• Regulatory pathway scoping, where the technology will need approval before it can be sold.

The output is usually described as a data package: the evidence a licensing negotiation or investor due-diligence process will ask for, assembled deliberately rather than accumulated by accident.

Structure

• Non-dilutive. Awards are structured as grants, not equity investments. This is much of their appeal — the discovery can be de-risked before anyone has to price it.
• Milestone-based. Funds are typically released against defined technical or commercial milestones rather than as a lump sum, and continuation depends on hitting them. Failing a milestone cleanly is an acceptable outcome; PoC programs are explicitly designed to produce fast negative answers as well as positive ones.
• Small and short. Typically far smaller than a research grant and running months rather than years, on the theory that the question being answered is narrow.
• Reviewed differently. Review panels usually include people from outside academia — entrepreneurs, licensing professionals, investors — and score commercial potential and milestone credibility alongside technical merit. An application that reads like a research proposal tends to score poorly.

Where it comes from

There is no single standardized PoC program. The sources fall into three groups:

• Funder-run schemes tied to a prior award, where holding an earlier grant from the same funder is the eligibility condition — the ERC Proof of Concept Grant being the best-known example of the pattern.
• University-run internal PoC or gap funds, administered by or alongside a technology-transfer office, often capitalised from licensing revenue or a donor endowment. These are the most numerous and the least visible from outside the institution.
• National or agency translational programs, such as NIH’s REACH program, which fund hubs or centres that in turn make PoC awards to their member institutions.

Where it sits in the commercialization path

The usual sequence is: research finding, invention disclosure, patent assessment and provisional filing, proof-of-concept award, then either licensing to an existing company or formation of a startup, followed by dilutive investment or non-dilutive translational funding such as SBIR/STTR. PoC funding is the step that makes the two later options possible: without it, a technology-transfer office is often trying to license a result whose commercial risk nobody has yet reduced.

Two things it is not. It is not a research grant with a commercialization paragraph attached — the milestones are the substance, not framing. And it is not startup funding: forming a company is a possible outcome of a PoC award, not what the award pays for.

Frequently Asked Questions

What is proof-of-concept funding used for?

It is typically used to build or refine a working prototype beyond a lab-scale result, run freedom-to-operate screening or file a provisional patent, validate the market or stakeholders through interviews with potential licensees or investors, and generate the data package a licensing negotiation or investor due-diligence process will ask for.

How is proof-of-concept funding different from seed funding?

Seed funding asks whether a research idea deserves initial support to generate the preliminary data needed to compete for a larger grant, and is judged against research-progress criteria. Proof-of-concept funding asks whether an already-existing result — a finding, invention, or prototype — is technically and/or commercially viable enough to license, spin out, or attract outside investment, and is judged against technology-readiness or commercialization milestones instead.

Where does proof-of-concept funding come from?

It comes from several distinct sources rather than one standardized program: funder-run schemes tied to a prior award, such as the ERC Proof of Concept Grant; university-run internal PoC or gap funds administered by or alongside a technology-transfer office; and national or agency translational programs such as NIH’s REACH program.

Do you need an existing invention disclosure to apply for proof-of-concept funding?

Most PoC schemes require a specific underlying discovery as the starting point — often a finding, invention, or prototype with a filed invention disclosure — and will not fund open-ended exploratory research. This is one of the main signals that distinguishes PoC funding from seed funding, which supports earlier-stage, more open-ended work.

Is proof-of-concept funding dilutive or non-dilutive?

It is typically non-dilutive: awards are structured as milestone-based grants rather than an equity investment, which is part of what makes them attractive for de-risking a discovery before it reaches a licensee, investor, or follow-on funder.